View, browse and sort the list of CPhI North America Conference sessions and show floor programming by pass type, track, and format. Seating is first come, first serve, so please arrive early to sessions that you would like to attend. Sessions are subject to change.

Matthew Bio, Ph.D.President & CEOSnapdragon Chemistry, Inc.

Dr. Matthew Bio is President & CEO at Snapdragon Chemistry. Matthew began his career in chemistry more than 20 years ago developing continuous processes for the manufacture and purification of acrylates at the former Rohm & Haas company. Matthew then moved to Columbia University and earned a PhD in Chemistry. Upon graduating, Matthew returned to industry as a process development chemist at Merck Research Laboratories. In 2006 Matthew moved to Amgen where he was Director of Process Development. At Amgen, Matthew led the development of both batch and continuous processes for clinical candidates and drove innovation in technologies for the manufacture of synthetic – biologic hybrid molecules. In 2015, Matthew joined Snapdragon Chemistry, Inc., a contract development firm specialized in the design of continuous manufacturing technology. Throughout his career, Matthew has been involved in the development of more than 50 clinical candidates and the launch of three new drugs to the market. He is author or inventor on more than 30 peer reviewed publications and patents and numerous regulatory filings. Matthew is driven by a passion for the development of new technologies in organic synthesis to enable safer, more efficient processes and providing access to new chemical architectures.

Presenting: